344 results on '"Yuza, Yuki"'
Search Results
2. Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia
3. High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia
4. Pathogenic role and diagnostic utility of interferon-α in histiocytic necrotizing lymphadenitis
5. Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study
6. Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndrome
7. Natto intake is a risk factor of Bacillus subtilis bacteremia among children undergoing chemotherapy for childhood cancer: A case-control study
8. Clinical characteristics and treatment of IMP-type carbapenemase-producing Enterobacteriaceae bacteremia: Case series and literature review
9. Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from Japan
10. Pharmacokinetic analysis of crushed venetoclax tablets combined with azacitizine for recurrent pediatric acute myeloid leukemia (AML)
11. Information needs of children with leukemia and their parents’ perspectives of their information needs: a qualitative study
12. Octreotide as prophylaxis against asparaginase-associated pancreatitis: a case series study.
13. Surgery for hepatoblastoma in children with trisomy 18: a monocentric study.
14. Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia with a Busulfan, Fludarabine, and Melphalan Regimen: JPLSG JMML-11
15. NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia
16. False-Positive Asymmetrical Tongue Muscle 18F-FDG Uptake in Hypoglossal Nerve Paralysis Following Lymph Node Dissection in a Pediatric Patient with Malignant Rhabdoid Tumor of the Neck
17. Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective
18. Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects
19. Inter‐reporter differences in symptom burdens in Japanese children with cancer
20. Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan
21. Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond–Blackfan anemia
22. Differential impact of asparaginase discontinuation on outcomes of children with T‐cell acute lymphoblastic leukemia and T‐cell lymphoblastic lymphoma.
23. Clinical and diagnostic utility of genomic profiling for digestive cancers: real-world evidence from Japan
24. Myeloproliferative disorder in a patient with RIT1‐associated Noonan syndrome: Case report and literature review
25. Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia
26. Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects
27. High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia
28. Genome-wide assessment of genetic risk loci for childhood acute lymphoblastic leukemia in Japanese patients
29. Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: A protocol for a randomized phase 2 trial
30. Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults
31. Myeloproliferative disorder in a patient with RIT1‐associated Noonan syndrome: Case report and literature review.
32. Rare TCF3 variants associated with pediatric B cell acute lymphoblastic leukemia.
33. Myeloproliferative disorder in a patient with RIT1 -associated Noonan syndrome: a case report and literature review
34. Challenges to Widespread Use of Fertility Preservation Facilities for Pediatric Cancer Patients in Japan
35. Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan
36. Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia
37. Correction: Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia
38. Transient myelodysplasia triggered by parvovirus B19 infection in a male with inborn error of bile acid metabolism
39. Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: A randomized phase 2 trial
40. Rare TCF3 variants associated with pediatric B cell acute lymphoblastic leukemia
41. Prevalence of pathogenic variants in cancer‐predisposing genes in second cancer after childhood solid cancers
42. Ewing’s Sarcoma with Extension into Superior Vena Cava and Right Atrium
43. Data from Glioblastoma-Derived Epidermal Growth Factor Receptor Carboxyl-Terminal Deletion Mutants Are Transforming and Are Sensitive to EGFR-Directed Therapies
44. Supplementary Table 1 from Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation
45. Supplementary Figure 2 from Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation
46. Supplementary Figure 5 from Glioblastoma-Derived Epidermal Growth Factor Receptor Carboxyl-Terminal Deletion Mutants Are Transforming and Are Sensitive to EGFR-Directed Therapies
47. Supplementary Figure 6 from Glioblastoma-Derived Epidermal Growth Factor Receptor Carboxyl-Terminal Deletion Mutants Are Transforming and Are Sensitive to EGFR-Directed Therapies
48. Supplementary Figure 2 from Glioblastoma-Derived Epidermal Growth Factor Receptor Carboxyl-Terminal Deletion Mutants Are Transforming and Are Sensitive to EGFR-Directed Therapies
49. Supplementary Methods, Figure Legends 1-3 from Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation
50. Supplementary Figure 3 from Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.